Sleep disorders in patients with severe mental depression: Double‐blind placebo‐controlled evaluation of the value of pipamperone (Dipiperon®)

DOI Web Site Web Site Web Site 被引用文献2件

抄録

<jats:p>Pipamperone was compared double‐blindly with placebo to evaluate its capacity to relieve sleep disorders in 40 depressive inpatients. At the end of the 1‐week trial, most of the items relating to sleep disturbances had improved significantly in the 24 patients of the pipamperone group whereas only a few items showed such a change in the control group. On the Hamilton depression scale, improvement in the pipamperone patients was also superior to that in the placebo group as regards the items “depressed mood” and “insight”. The adequate median daily dose of pipamperone appeared to be 80 mg (2 tablets).</jats:p>

収録刊行物

被引用文献 (2)*注記

もっと見る

キーワード

問題の指摘

ページトップへ